期刊
LASERS IN MEDICAL SCIENCE
卷 36, 期 5, 页码 935-938出版社
SPRINGER LONDON LTD
DOI: 10.1007/s10103-020-03206-9
关键词
Coronavirus; Low-level light therapy; Respiratory distress syndrome; adult; Inflammation; COVID-19; Photobiomodulation
COVID-19 has become a global concern, with patients showing different symptoms based on disease severity. While the host immune system can successfully eliminate the virus in mild cases, it may lead to acute respiratory distress syndrome in severe cases. Photobiomodulation has shown promising results in reducing acute pulmonary inflammation and may be an effective treatment modality for managing ARDS in COVID-19 patients.
COVID-19 is now a worldwide concern, causing an unprecedented pandemic. The infected cases show different symptoms based on the severity of the disease. In asymptomatic and non-severe symptomatic cases, the host immune system can successfully eliminate the virus and its effects. In severe cases, however, immune system impairment causes cytokine release syndrome which eventually leads to acute respiratory distress syndrome (ARDS). In recent years, photobiomodulation (PBM) has shown promising results in reducing acute pulmonary inflammation. Considering the high potential impact of PBM on immune responses, we hypothesized that using PBM could be an effective treatment modality for ARDS management in COVID-19 patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据